$3.40
0.030.89%
At close: Aug 28, 5:00 PM EST
Can Fite Biopharma Ltd
CANFAMEX
Can Fite Biopharma Earnings & Forecasts
Can Fite Biopharma (CANF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Can Fite Biopharma Guidance
Recent Earnings Results
| Metric | H1 '25 | H1 '24 | Q4 '23 | Q3 '23 | FY '25 | FY '24 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | $-2.80 | $-0.40 | $-0.26 | $-0.44 | $-10.40 | — |
| Actual | $0.00 | $0.00 | $-0.01 | $-0.43 | $-5.97 | $0.00 |
| Surprise | +100.0% | +100.0% | +96.2% | +2.27% | +42.6% | — |
| Revenue | ||||||
| Estimate | — | $150000 | $100000 | $100000 | $202000 | $500000 |
| Actual | $202000 | $316000 | $155000 | $196000 | $405000 | $674000 |
| Surprise | — | +110.7% | +55.0% | +96.0% | +100.5% | +34.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | H1 '26E | FY '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.43 | $-0.68 |
| Revenue | ||
| Consensus | — | — |
